We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

TTGT:NASDAQTechTarget, Inc. Analysis

Data as of 2026-05-06 - not real-time

$5.95

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

TechTarget, Inc. is trading at a steep discount to its intrinsic valuation, with the DCF model indicating a fair value far above the current market price. Revenue is growing at roughly 40% YoY and gross margins sit comfortably above 60%, but operating efficiency remains weak, reflected in a sub‑10% operating margin and a negative trailing profit margin. The forward earnings outlook turns positive, and a consensus of three analysts rates the stock as a strong buy, reinforcing the upside narrative. Despite the lack of dividend payments, the balance sheet shows modest cash relative to debt, and free cash flow is positive, suggesting the company can sustain operations while it works toward profitability.
On the technical side, the stock sits in the overbought region of the RSI, while the MACD line has recently crossed above its signal, signaling short‑term bullish momentum that may be fragile. Volume trends are decreasing and the 30‑day volatility exceeds 80%, indicating a potentially choppy price environment. The beta above 1.3 points to heightened sensitivity to market swings, and the price is positioned between a clear support level near $3.60 and resistance around $6.20, leaving limited upside in the immediate term but substantial room for a longer‑term rally if fundamentals materialize.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • RSI in overbought territory suggests limited near‑term upside
  • Decreasing volume and high short‑term volatility
  • Price near resistance with limited catalyst in the next few weeks

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong revenue growth and improving cash flow
  • DCF valuation indicating ~68% upside potential
  • Analyst consensus of strong‑buy and favorable forward EPS

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Undervalued relative to industry PE and intrinsic fair value
  • Strategic positioning in intent‑driven advertising and AI‑enhanced solutions
  • Potential for margin expansion as operating efficiencies improve

Key Metrics & Analysis

Financial Health

Revenue Growth40.10%
Profit Margin-207.13%
P/E Ratio7.3
ROE-93.08%
ROA-1.26%
Debt/Equity18.71
P/B Ratio0.7
Op. Cash Flow$16.3M
Free Cash Flow$77.5M
Industry P/E37.2

Technical Analysis

TrendNeutral
RSI71.9
Support$3.61
Resistance$6.20
MA 20$5.05
MA 50$4.33
MA 200$5.35
MACDBullish
VolumeDecreasing
Fear & Greed Index90.48

Valuation

Fair Value$37.86
Target Price$10.00
Upside/Downside68.07%
GradeUndervalued
TypeGrowth

Risk Assessment

Beta1.36
Volatility80.62%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.